2cureX AB (publ) (STO:2CUREX)
Sweden · Delayed Price · Currency is SEK 1.220
-0.160 (-11.59%)
Jan 21, 2026, 3:09 PM CET
2cureX AB Market Cap
2cureX AB has a market cap or net worth of 34.64 million as of January 21, 2026. Its market cap has increased by 382.35% in one year.
Market Cap
34.64M
Enterprise Value
31.51M
Revenue
1.98M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.22
Market Cap Chart
Since November 24, 2017, 2cureX AB's market cap has decreased from 83.32M to 34.64M, a decrease of -58.42%. That is a compound annual growth rate of -10.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 34.64M | 168.48% |
| Dec 30, 2025 | 12.90M | 73.70% |
| Dec 30, 2024 | 7.43M | -79.00% |
| Dec 29, 2023 | 35.38M | -75.34% |
| Dec 30, 2022 | 143.46M | -51.13% |
| Dec 30, 2021 | 293.59M | 19.49% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 24, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Karolinska Development AB | 83.38M |
| Scandinavian ChemoTech AB | 82.87M |
| Alzinova AB | 82.10M |
| Spago Nanomedical AB | 76.41M |
| OncoZenge AB | 72.97M |
| Nanologica AB | 55.85M |
| AcouSort AB | 55.03M |
| ExpreS2ion Biotech Holding AB | 53.94M |